$1.20
0.043.45%
At Close: -
$1.21
0.010.83%
After Hours: 6:03 PM EDT
15 minutes delayed
Adaptimmune Therapeutics
ADAPNASDAQ
Adaptimmune Therapeutics (NASDAQ:ADAP) Stock, Short Interest Report
Short interest in Adaptimmune Therapeutics PLC (NASDAQ:ADAP) increased during the last reporting period, rising from 4.62M to 4.90M. This put 2.88% of the company's publicly available shares short.
Short interest for Adaptimmune Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Adaptimmune Therapeutics's stock. Short interest data is updated every two weeks.
Based on the recent average volume of 1.62M shares traded per day, it would take 3.02 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.
Short Interest
4.90M
Short Interest %
2.88%
Days to Cover
3.02
| Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| ADAP | Adaptimmune Therapeutics plc A | 06/14/2024 | 06/26/2024 | 2.88% | 170,350,212 | 4,903,957 | 1,623,020 | 3.02 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 05/31/2024 | 06/11/2024 | 2.71% | 170,350,212 | 4,621,117 | 2,449,841 | 1.89 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 05/15/2024 | 05/24/2024 | 2.02% | 170,350,212 | 3,441,159 | 832,969 | 4.13 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 04/30/2024 | 05/09/2024 | 2.06% | 170,350,212 | 3,517,477 | 1,193,320 | 2.95 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 04/15/2024 | 04/24/2024 | 2.00% | 170,350,212 | 3,407,756 | 1,320,412 | 2.58 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 03/28/2024 | 04/09/2024 | 1.88% | 170,284,046 | 3,197,059 | 1,405,327 | 2.27 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 03/15/2024 | 03/26/2024 | 2.89% | 107,581,286 | 3,112,390 | 2,408,238 | 1.29 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 02/29/2024 | 03/11/2024 | 2.60% | 107,581,286 | 2,800,124 | 1,606,871 | 1.74 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 02/15/2024 | 02/27/2024 | 2.72% | 107,581,286 | 2,928,624 | 2,035,389 | 1.44 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 01/31/2024 | 02/09/2024 | 4.38% | 107,581,286 | 4,710,050 | 2,503,674 | 1.88 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 01/12/2024 | 01/24/2024 | 5.36% | 107,581,286 | 5,765,134 | 880,263 | 6.55 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 12/29/2023 | 01/10/2024 | 5.30% | 107,581,286 | 5,703,578 | 1,113,538 | 5.12 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 12/15/2023 | 12/27/2023 | 5.69% | 107,581,286 | 6,123,889 | 566,587 | 10.81 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 11/30/2023 | 12/11/2023 | 5.74% | 107,581,286 | 6,170,818 | 469,066 | 13.16 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 11/15/2023 | 11/27/2023 | 5.57% | 107,581,286 | 5,990,432 | 338,434 | 17.7 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 10/31/2023 | 11/09/2023 | 5.43% | 107,581,286 | 5,846,727 | 425,152 | 13.75 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 10/13/2023 | 10/24/2023 | 6.22% | 107,581,286 | 6,694,686 | 417,253 | 16.04 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 09/29/2023 | 10/10/2023 | 5.54% | 107,581,286 | 5,965,238 | 389,120 | 15.33 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 09/15/2023 | 09/26/2023 | — | — | 6,045,098 | 475,525 | 12.71 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 08/31/2023 | 09/12/2023 | — | — | 5,870,902 | 343,004 | 17.12 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 08/15/2023 | 08/24/2023 | — | — | 5,762,250 | 543,129 | 10.61 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 07/31/2023 | 08/09/2023 | 3.88% | 148,060,000 | 5,739,521 | 738,229 | 7.77 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 07/14/2023 | 07/25/2023 | 3.82% | 148,060,000 | 5,656,350 | 627,561 | 9.01 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 06/30/2023 | 07/12/2023 | 4.08% | 146,750,000 | 5,989,046 | 1,288,092 | 4.65 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 06/15/2023 | 06/27/2023 | 5.08% | 146,750,000 | 7,449,459 | 1,238,581 | 6.01 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 05/31/2023 | 06/09/2023 | 6.79% | 146,750,000 | 9,959,746 | 965,543 | 10.32 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 05/15/2023 | 05/24/2023 | 6.24% | 146,750,000 | 9,156,753 | 588,369 | 15.56 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 04/28/2023 | 05/09/2023 | 6.16% | 145,770,000 | 8,984,102 | 911,931 | 9.85 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 04/14/2023 | 04/25/2023 | 5.14% | 145,770,000 | 7,490,655 | 744,998 | 10.05 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 03/31/2023 | 04/12/2023 | 4.62% | 145,770,000 | 6,733,303 | 668,996 | 10.06 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 03/15/2023 | 03/24/2023 | 3.59% | 145,770,000 | 5,229,426 | 1,334,366 | 3.92 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 02/28/2023 | 03/09/2023 | 1.98% | 145,770,000 | 2,891,232 | 162,079 | 17.84 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 02/15/2023 | 02/27/2023 | 1.96% | 145,160,000 | 2,844,333 | 223,605 | 12.72 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 01/31/2023 | 02/09/2023 | 1.93% | 145,160,000 | 2,799,094 | 332,582 | 8.42 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 01/13/2023 | 01/25/2023 | 1.87% | 145,120,000 | 2,709,076 | 502,696 | 5.39 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 12/30/2022 | 01/11/2023 | 2.03% | 145,120,000 | 2,945,520 | 374,269 | 7.87 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 12/15/2022 | 12/27/2022 | 1.89% | 145,120,000 | 2,743,557 | 353,580 | 7.76 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 11/30/2022 | 12/09/2022 | 1.91% | 145,070,000 | 2,777,231 | 423,977 | 6.55 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 11/15/2022 | 11/25/2022 | 2.60% | 144,700,000 | 3,762,433 | 739,359 | 5.09 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 10/31/2022 | 11/09/2022 | 2.31% | 144,700,000 | 3,341,495 | 822,881 | 4.06 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 10/14/2022 | 10/25/2022 | 2.57% | 144,700,000 | 3,712,415 | 288,776 | 12.86 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 09/30/2022 | 10/11/2022 | 2.75% | 144,520,000 | 3,972,334 | 464,155 | 8.56 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 09/15/2022 | 09/26/2022 | 2.57% | 144,010,000 | 3,706,660 | 313,027 | 11.84 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 08/31/2022 | 09/12/2022 | 2.57% | 144,010,000 | 3,699,194 | 224,706 | 16.46 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 08/15/2022 | 08/24/2022 | 2.53% | 144,010,000 | 3,641,070 | 307,464 | 11.84 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 07/29/2022 | 08/09/2022 | — | — | 3,722,201 | 179,519 | 20.73 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 07/15/2022 | 07/26/2022 | — | — | 4,043,161 | 304,206 | 13.29 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 06/30/2022 | 07/12/2022 | — | — | 3,910,842 | 502,185 | 7.79 | Get Alert |
Looking for the most shorted stocks?